does identity actually matter or is it forum lore at this point
Asking properly rather than in a comment on somebody else’s thread: does identity actually matter or is it forum lore at this point.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Happy to answer the boring questions. Those are usually the ones worth asking.
best — the order this archive was captured in
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
Net peptide content on the certificate was well below the purity figure and both were honest. Chemistry, not deception.
purity methods differ between compound classes
Yes. Naming conventions in this corner are loose enough that the same word covers several different molecules.
Stocked line or made to order — did they say?
Has anyone here tested that compound at all?
That method was developed for a different compound class and would not resolve the impurities you are asking about.
identity before purity, every time, for anything unusual
Asked TFC which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
Cosigning the lead-time point. Made-to-order and stocked are completely different propositions and both are legitimate.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
Same. Net peptide content is where the difference between the label and the vial actually shows up.
Agreed that thin testing here says something about the members, not about the material.
Correction: that name covers two different molecules and the thread has been discussing both as one.
if nobody has tested it here, that is a fact about us, not the compound
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
Asked for a catalogue number rather than removing. Common names are ambiguous here and it makes threads unusable later.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Storage guidance that names a temperature, a state and a duration reflects actual stability work.
britt_zamora is right that a purity figure without a method is not comparable to one with a method.
Right — QSC answered a handling question with actual storage conditions rather than a generic line, which is the standard.
Right — QSC answered a handling question with actual storage conditions rather than a generic line, which is the standard.
Disagreeing with this bit: handling for one compound does not transfer to another by default.
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
- 1Confirmed the lead time in writing before ordering a made-to-order line. It…12 comments in this branch · started by u/second_week_sceptic
- 2Naming in this space is inconsistent. Several widely used names map to more…7 comments in this branch · started by u/marit_laurent